These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9632348)

  • 41. Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor.
    Ishikawa M; Furuuchi T; Yamauchi M; Yokoyama F; Kakui N; Sato Y
    Bioorg Med Chem; 2010 Jul; 18(14):5441-8. PubMed ID: 20541426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
    J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
    Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
    Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatostatin receptors in Neuro2A neuroblastoma cells: operational characteristics.
    Koenig JA; Edwardson JM; Humphrey PP
    Br J Pharmacol; 1997 Jan; 120(1):45-51. PubMed ID: 9117097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.
    Ren SG; Kim S; Taylor J; Dong J; Moreau JP; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5414-21. PubMed ID: 14602782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxindole derivatives as orally active potent growth hormone secretagogues.
    Tokunaga T; Hume WE; Umezome T; Okazaki K; Ueki Y; Kumagai K; Hourai S; Nagamine J; Seki H; Taiji M; Noguchi H; Nagata R
    J Med Chem; 2001 Dec; 44(26):4641-9. PubMed ID: 11741481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of oral absorption in selective 5-HT1D receptor agonists: fluorinated 3-[3-(piperidin-1-yl)propyl]indoles.
    Castro JL; Collins I; Russell MG; Watt AP; Sohal B; Rathbone D; Beer MS; Stanton JA
    J Med Chem; 1998 Jul; 41(15):2667-70. PubMed ID: 9667955
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.
    Ben-Shlomo A; Schmid H; Wawrowsky K; Pichurin O; Hubina E; Chesnokova V; Liu NA; Culler M; Melmed S
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4342-50. PubMed ID: 19820006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
    Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
    Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
    Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
    J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.
    Gu YZ; Brown PJ; Loose-Mitchell DS; Stork PJ; Schonbrunn A
    Mol Pharmacol; 1995 Dec; 48(6):1004-14. PubMed ID: 8847999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells.
    Strowski MZ; Dashkevicz MP; Parmar RM; Wilkinson H; Kohler M; Schaeffer JM; Blake AD
    Neuroendocrinology; 2002 Jun; 75(6):339-46. PubMed ID: 12065886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers.
    Li G; Low PS
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1792-1798. PubMed ID: 25791453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivities.
    Feytens D; De Vlaeminck M; Cescato R; Tourwé D; Reubi JC
    J Med Chem; 2009 Jan; 52(1):95-104. PubMed ID: 19067538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists.
    Contour-Galcéra MO; Sidhu A; Plas P; Roubert P
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3555-9. PubMed ID: 15982879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.
    Brodney MA; Johnson DE; Sawant-Basak A; Coffman KJ; Drummond EM; Hudson EL; Fisher KE; Noguchi H; Waizumi N; McDowell LL; Papanikolaou A; Pettersen BA; Schmidt AW; Tseng E; Stutzman-Engwall K; Rubitski DM; Vanase-Frawley MA; Grimwood S
    J Med Chem; 2012 Nov; 55(21):9240-54. PubMed ID: 22974325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A facile chemo-, regio- and stereoselective synthesis and cholinesterase inhibitory activity of spirooxindole-pyrrolizine-piperidine hybrids.
    Kia Y; Osman H; Kumar RS; Murugaiyah V; Basiri A; Perumal S; Razak IA
    Bioorg Med Chem Lett; 2013 May; 23(10):2979-83. PubMed ID: 23570788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory control of growth hormone secretion by somatostatin in rat pituitary GC cells: sst(2) but not sst(1) receptors are coupled to inhibition of single-cell intracellular free calcium concentrations.
    Cervia D; Petrucci C; Bluet-Pajot MT; Epelbaum J; Bagnoli P
    Neuroendocrinology; 2002 Aug; 76(2):99-110. PubMed ID: 12169771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.